Testicular microlithiasis (TM) has been reported in up to 46% of men with testicular cancer.
This has given rise to the suspicion that TM is a premalignant condition. In studies of healthy men there is, however, no association between TM and development of cancer. Nonetheless, patients with TM and contralateral testicular cancer, testicular atrophy, inhomogeneous parenchyma, infertility or a history of maldescensus are at increased risk of having carcinoma in situ (CIS) and cancer development. Men with TM and one or more of the above mentioned risk factors should be offered a testicular biopsy to rule out CIS.
Written by:
Fode M, Giwercman A, Bisbjerg R, Sønksen J. Are you the author?
Urologisk Afdeling, Herlev Hospital, Herlev -Ringvej 75, 2730 Herlev.
Reference: Ugeskr Laeger. 2014 Aug 18;176(34). pii: V02130145.
PubMed Abstract
PMID: 25293560
Article in Danish.